Comments to FDA: INDs - Determining Whether Human Research Studies Can Be Conducted Without an IND

Share page:
Docket Number:
FDA-2010-D-0503

Letter regarding FDA draft guidance entitled “Investigational New Drug Applications (INDs) – Determining Whether Human Research Studies Can Be Conducted Without an Investigational New Drug Application.” These comments are focused on issues related to dietary supplements as referenced in the draft guidance.

Related Posts

CHPA Statement on Valisure Citizen Petition